Molecular analysis of the PML/RARα chimeric gene in pediatric acute promyelocytic leukemia

Leukemia

Volumn 10, Issue 8, 1996, Pages 1296-1302

  Kane, J R ^a   Head, D R ^a,b   Balazs, L ^a   Hulshof, M C ^a   Motroni, T A ^a   Raimondi, S C ^a,b   Carroll, A J ^c,d   Behm, F C ^a,b   Krance, R A ^a   Shurtleff, S A ^a   Downing, J R ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Pediatric Oncology Group   (United States)

Author keywords

Acute promyelocytic leukemia; bcr; Pediatric; PML RAR ; RT PCR; t(15; 17)

Indexed keywords

CD22 ANTIGEN;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; CHIMERA; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTRON; LEUKOCYTE COUNT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

EID: 9344224532     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Rowley JD, Golomb HM, Dougherty C. 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet 1977; 1: 549-550.
2. Stone RM, Mayer RJ. The unique aspects of acute promyelocytic leukemia. J Clin Oncol 1990; 8: 1913-1921.
3. Mayer RJ, Schiffer CA, Peterson BA, Budman DR, Silver RT, Rai KR, Cornwell CG, Ellison RR, Maguire M, Berg DT. Intensive post-remission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from CALGB. Cancer and Leukemia Group B. Semin Oncol 1987; 14 (Suppl. 1): 25-31.
4. Valdivieso M, Rodriguez V, Drewinko B, Bodey CP, Ahearn MJ, McCredie K, Freireich EJ. Clinical and morphological correlations in acute promyelocytic leukemia. Med Ped Oncol 1975; 1: 37-50.
5. Raimondi SC, Kalwinsky DK, Hayashi Y, Behm FC, Mirro J, Williams DL. Cytogenetics of childhood acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1989; 40: 13-27.
6. Creutzig U, Ritter J, Riehm H, Langermann I, Henze G, Kabisch H, Niethammer D, Jürgens H, Stollmann B, Lasson V, Kaufmann U, Löfler H, Schellong G. Improved treatment results in childhood acute myelogenous leukemia: a report of the German Cooperative study AML-BFM-78. Blood 1985; 65: 298-304.
7. Chessells JM, O'Callaghan U, Hardisty RM. Acute myeloid leukaemia in childhood: clinical features and prognosis. Br J Haematol 1986; 63: 555-564.
8. Carter M, Kalwinsky DK, Dahl GV, Santana VM, Mason CA, Schell MJ. Childhood acute promyelocytic leukemia: a rare variant non-lymphoid leukemia with distinctive clinical and biological features. Leukemia 1989; 3: 298-302.
9. Davey FR, Davis RB, MacCallum JM, Nelson DA, Mayer RJ, Ball ED, Griffin JD, Schiffer CA, Bloomfield CD. Morphologic and cytochemical characteristics of acute promyelocytic leukemia. Am J Hematol 1989; 30: 221-227.
10. Bennett JM, Catovsky D, Daniel MT, Flandrin C, Galton DAG, Gralnick HR, Sultan C. A variant form of hypergranular promyelocytic leukemia (M3). Ann Intern Med 1980; 92: 261.
11. Golomb HM, Rowley JD, Vardiman JW, Testa JR, Butler A. 'Microgranular' acute promyelocytic leukemia: a distinct clinical, ultrastructural and cytogenetic entity. Blood 1980; 55: 253-259.
12. Rovelli A, Biondi A, Cantù Rajnoldi A, Conter V, Giudici G, Jankovic M, Locasciulli A, Rizzari C, Romitti L, Rossi MR, Schirò R, Tosi S, Uderzo C, Masera G. Microgranular variant of acute promyelocytic leukemia in children. J Clin Oncol 1992; 10: 1413-1418.
13. Cunningham I, Gee TS, Reich LM, Kempin SJ, Naval AN, Clarkson BD. Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital. Blood 1989; 73: 1116-1122.
14. Kantarjian HM, Keating MJ, Walters RS, Estey EH, McCredie KB, Smith TL, Dalton WT, Cork A, Trujillo JM, Freireich EJ. Acute promyelocytic leukemia: the MD Anderson Hospital experience. Am J Med 1986; 80: 789-797.
15. Huang M-E, Ye Y-C, Chen S-R, Chai J-R, Lu J-X, Zhoa L, Gu L-J, Wang Z-Y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567-572.
16. Warrell RP, Frankel SR, Miller WH, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove I, Cordon MS, Dmitrovsky E. Differentiation therapy for acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). New Engl J Med 1991; 324: 1385-1395.
17. Kanamaru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T, Kuriyama K, Ohmoto E, Sakamaki H, Tsubaki K, Hiraoka A, Yamada O, Oh H, Saito K, Matsuda S, Minato K, Ueda T, Ohno R. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 1995; 85: 1202-1206.
18. Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H, Guerci A, Duarte M, Daniel MT, Bowen D, Huebner G, Bauters F, Fegueux N, Fey M, Sanz M, Löwenberg B, Maloisel F, Auzanneau G, Sadoun A, Gardin C, Bastion Y, Ganser A, Jacky E, Dombert H, Chastang C, Degos L. Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood 1993; 82: 3241-3249.
19. Head DR, Kopecky KJ, Willman C, Appelbaum FR. Treatment outcome with chemotherapy in acute promyelocytic leukemia. The Southwest Oncology Group experience. Leukemia 1994; 8: S38-S41.
20. Cantú-Rajnoldi A, Biondi A, Jankovic M, Masera G, Rovelli A, Uderzo C, Head D, Raimondi S, Creutzig U, Ritter J, Mirro J. Diagnosis and incidence of acute promyelocytic leukemia (FAB M3 and m3 variant) in childhood. Blood 1993; 81: 2209-2210.
21. Douer D, Preston-Smith S, Chang E, Nichols PW, Watkins KJ, Levine AM. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood 1996; 87: 308-313.
22. Gilbert RD, Karabus CD, Mills AE. Acute promyelocytic leukemia: a childhood cluster. Cancer 1987; 59: 933-935.
23. De Salvo L, Weir Medina J, Gómez Sánchez O, de Baena ES, de Ramos BU, Guevara J, Leungo Vera J, de Vizcaíno MA, Sánchez H, de León E, Leal I, Salas D, Merino F. Leucemia promielocítica aguda en el occidente de Venezuela. Sangre 1989; 34: 329-331.
24. Malta Corea A, Pacheco Espinoza C, Cantù Rajnoldi A, Lietti G, Masera G, Sessa C, Cavalli F, Biondi A, Rovelli A. Childhood acute promyelocytic leukemia in Nicaragua. Ann Oncol 1993; 4: 892-894.
25. Loureiro P, Azevedo A, Maia A, Freire AD, Souto F, Bandeira F, Vasconcelos J, Paiva A. Acute myeloid leukemia, presentation of the disease and response to treatment in Northeast of Brazil, Recife. Med Ped Oncol 1992; 20: 439a.
26. de Thè H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor a gene to novel transcribed locus. Nature 1990; 347: 558-561.
27. Lemons RS, Eilender D, Waldmann RA, Rebentisch M, Frej AK, Ledbetter DM, Willmann C, McConnell T, O'Connell P. Cloning and characterization of the t(15;17) translocation breakpoint region in acute promyelocytic leukemia. Genes Chromosom Cancer 1990; 2: 79-87.
28. Borrow J, Goddard AD, Sheer D, Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990; 249: 1577-1580.
29. Pandolfi PP, Grignani F, Alcalay M, Mencarelli A, Biondi A, Lo Coco F, Grignani F, Pelicci PG. Structure and origin of the acute promyelocytic leukemia my1/RARα cDNA and characterization of its retinoid-building and transactivation properties. Oncogene 1991; 6: 1285-1292.
30. de Thè H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991; 66: 675-684.
31. Kakizuka A, Miller WH, Umesono K, Warrell RP, Frankel SR, Murty VS, Dmitrovsky E, Evans RM. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARa with a novel putative transcription factor, PML. Cell 1991; 66: 663-675.
32. Grignani Fr, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I, Pelicci PG. The acute promyelocytic leukemia specific PML/RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 1993; 74: 423-431.
33. Alcalay M, Zangrilli D, Fagioli M, Pandolfi PP, Mencarelli A, Lo Coco F, Biondi A, Grignani F, Pelicci PC. Expression pattern of the RARa-PML fusion gene in acute promyelocytic leukemia. Proc Natl Acad Sci USA 1992; 89: 4840-4844.
34. Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D, Biondi A, Lo Coco F, Rambaldi A, Grignani F, Rochette-Egly C, Gaube M-P, Chambon P, Pelicci PG. Genomic variability and alternative splicing generate multiple PML/RARα transcripts that encode aberrant PML proteins and PML/RARα isoforms in acute promyelocytic leukemia. EMBO J 1992; 11: 1397-1407.
35. Geng J-P, Tong J-H, Dong S, Wang Z-Y, Chen S-J, Chen Z, Zelent A, Berger R, Larsen C-J. Localization of the chromosome 15 breakpoints and expression of multiple PML/RARa transcripts in acute promyelocytic leukemia: a study of 28 Chinese patients. Leukemia 1993; 7: 20-26.
36. Biondi A, Rambaldi A, Pandolfi PP, Rossi V, Giudici G, Alcalay M, Lo Coco F, Diverio D, Pogliani EM, Lanzi EM, Mandelli F, Masera G, Barbui T, Pelicci PG. Molecular monitoring of the myl/retinoic acid receptor-α fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood 1992; 80: 492-497.
37. Miller WH, Kakizuka A, Frankel SR, Warrell RP, DeBlasio A, Levine K, Evans R, Dmitrovsky E. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor a clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci USA 1992; 89: 2694-2698.
38. Castaigne S, Balitrand N, de Thé H, Dejean A, Degos L, Chomienne C. A PML/retinoic acid receptor a fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. Blood 1992; 79: 3110-3115.
39. Chen S-J, Chen Z, Chen A, Tong J-H, Dong S, Wang Z-Y, Waxman S, Zelent A. Occurrence of distinct PML-RARα fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction. Oncogene 1992; 7: 1223-1232.
40. Ikeda K, Sasaki K, Tasaka T, Nagai M, Kawanishi K, Takahara J, Irino S. Reverse transcription-polymerase chain reaction for PML/RARα fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection. Leukemia 1993; 7: 544-548.
41. Claxton DF, Reading CL, Nagarajan L, Tsujimoto Y, Andersson BS, Estey E, Cork A, Huh YO, Trujillo J, Deisseroth AB. Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood 1992; 80: 582-586.
42. Bennett JB, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985; 103: 620-625.
43. ISCN (1991) Mitelman F (ed). Guidelines for Cancer Cytogenetics, Supplement to an International System for Human Cytogenetic Nomenclature. Karger: Basel, 1991, pp 1-54.
44. Hurwitz CA, Raimondi SC, Head D, Krance R, Mirro J, Kalwinsky DK, Ayers GD, Behm FG. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood 1992; 80: 3182-3188.
45. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
46. Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 1975; 45: 321-334.
47. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991; 77: 1080-1086.
48. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte IN, McCormick FP. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 1988; 85: 5698-5702.
49. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-238.
50. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503-517.
51. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467.
52. Gallagher R, Rao S, Etkind P, Peng S, Qiu L, Wiernik P. Variable expression of PML-RARα mRNA isoforms in acute promyelocytic leukemia patients. Proc Annu Meet Am Assoc Cancer Res 1993; 34: 3173a.
53. Gallagher R, Willman C, Slack J, Andersen J, Li Y, Viswanatha D, Bloomfield C, Appelbaum F, Schiffer C, Tallman M, Wiernik P. Correlation of PML-RARα mRNA type with pretreatment clinical characteristics and achievement of complete remission (CR) in acute promyelocytic leukemia (APL): an intergroup study. Blood 1995; 86: 729a.
54. Chen C-S, Medberry PS, Arthur DC, Kersey JH. Breakpoint clustering in t(4;11)(q21;q23) acute leukemia. Blood 1991; 78: 2498-2504.
55. Downing JR, Head DR, Curcio-Brint AM, Hulshof MG, Motroni TA, Raimondi SC, Carroll AJ, Drabkin HA, Willman C, Theil KS, Civin CI, Erickson P. An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood 1993; 81: 2860-2865.
56. Claxton DF, Liu P, Hsu HB, Marlton P, Hester J, Collins F, Deisseroth AB, Rowley JD, Siciliano MJ. Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood 1994; 83: 1750-1756.
57. Miller WH, Heller G, Warrell RP. Implications of the PML/RAR-α isoform at presentation and detection of PML/RAR-α by reverse transcription polymerase chain reaction (RT-PCR) in remission of acute promyelocytic leukemia (APL). Blood 1994; 84: 379a.